// App-Quantinova.ai

5115 : Characterization of Common Fusion Oncogenes As Prognostic Molecular Identities in Adult Acute Lymphoblastic Leukemia Identifies the Need for Genetic Testing At Presentation, Molecular Prognostication and Differential Treatment

Researchers

Presenter

  • Sabir Noreen

Principal Investigators

  • Muhammad Farooq Sabar

  • Mahmood Rasool

  • Agha Shabbir Ali

  • Amer Mahmood

  • Muhammad Akram

  • Tariq Saeed

  • Saleem Arsalan

  • Danish Mohsin

  • Awan Tashfeen

  • Ijaz Husssain Shah

  • Muhammad Khalid

  • Muhammad Asif

  • Mudassar Iqbal

  • Tanveer Akhtar

  • Tahir Naeem

  • Asad Sultan

  • Ammara H Tahir

  • Muhammad Absar

  • Muhammad Azhar Chishti

  • Muhammad Faiyaz -ul-Haque

  • Ahmed Mukhtar Khalid

Medical Centers

  • Asian Medical Institute, Bishkek, Kyrgyzstan

  • Department of Medicine, College of Medicine and King Khalid University Hospital, King Saud University, Hematology/Oncology Division, Saudi Arabia

  • Department of Pathology, Mircobiology Unit, College of Medicine and King Khalid University Hospital, Riyadh, Saudi Arabia

  • School of Biological Sciences, University of Sargodha, Sargodha, Pakistan

  • Department of Oncology, Allama Iqbal Medical College and Jinnah Hospital, Lahore, Pakistan

  • Kant Kyrgyzstan & Post Graduate Medical Institute & Department of Zoology, Hematology, Oncology and Pharmacogenetic Engineering Sciences HOPES Group, Lahore, Pakistan

  • College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia

  • National Centre of Excellence in Molecular Biology, Lahore, Pakistan, Centre for Advanced Molecular Biology, Lahore, Pakistan

  • Department of Anatomy, Stem Cell Research Laboratory, Riyadh, Saudi Arabia

  • College of Applied Medicine, King Saud Bin Abdulaziz University of Health Sciences, Riyadh, Saudi Arabia

  • Department of Pathology, Mircobiology Unit, College of Medicine and King Khalid University Hospital, Riyadh, Saudi Arabia

  • Lahore, Pakistan

  • Department of Haematology, Univeristy of Health Sciences, Lahore, Pakistan

  • Department of Oncology,, Punjab Medical College and Allied Hospital,, Faisalabad, Pakistan

  • Department of Zoology, Hematology, Oncology and Pharmacogenetic Engineering Sciences HOPES Group, Lahore, Pakistan

  • Department of Biotechnology and Informatics, BUITEMS, Quetta, Pakistan

  • Centre for Advanced Molecular Biology & Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, ., Hematology, Oncology and Pharmacogenetic Engineering Sciences HOPES Group, Lahore, Pakistan

  • Univ. of Health Sciences, Lahore, Pakistan

  • Centre of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia

  • Department of Zoology, Hematology, Oncology and Pharmacogenetic Engineering Sciences HOPES Group, Health Sciences Laboratories, Faculty of Biological Sciences, Lahore, Pakistan

Locations

  • Saudi Arabia

  • Kyrgyzstan

  • Pakistan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • ETV6-RUNX1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved